Aspiration Pneumonia

Topic Overview

Summary

Aspiration pneumonia is a pulmonary infection resulting from inhalation of oropharyngeal or gastric contents into the lower respiratory tract. It represents a distinct clinical entity within the spectrum of aspiration-related lung disease, occurring predominantly in patients with impaired swallowing mechanisms or reduced level of consciousness. The condition is characterised by inflammation and bacterial infection of lung parenchyma, typically involving dependent lung segments (particularly the right lower lobe and posterior segments of upper lobes). Unlike community-acquired pneumonia, aspiration pneumonia is associated with distinct risk factors (dysphagia, stroke, neurodegenerative disease, reduced consciousness), microbiology (polymicrobial with potential anaerobic involvement), and management considerations (including swallow assessment and aspiration prevention strategies). [1,2]

Key Facts

• Incidence: Accounts for 5-15% of community-acquired pneumonia; up to 30% in nursing home residents [3]
• Pathogenesis: Failure of airway protective mechanisms → aspiration of colonised oropharyngeal/gastric contents → chemical injury and/or bacterial infection
• Spectrum: Ranges from chemical pneumonitis (Mendelson syndrome) to bacterial aspiration pneumonia
• Risk factors: Dysphagia (stroke, Parkinson's, dementia), reduced consciousness (GCS less than 8, alcohol, sedatives), GERD, mechanical disruption (NG tube, tracheostomy), poor oral hygiene [4,5]
• Microbiology: Polymicrobial; includes aerobic gram-positives (Streptococcus pneumoniae, Staphylococcus aureus), gram-negatives (Haemophilus influenzae, Enterobacteriaceae), and potentially anaerobes (Peptostreptococcus, Prevotella, Bacteroides) [6]
• Anatomical distribution: Right lower lobe most common (right main bronchus more vertical and wider); posterior segments if supine aspiration [7]
• Treatment: Empirical antibiotics covering typical and atypical organisms, with consideration of anaerobic coverage in specific contexts; swallow assessment and aspiration prevention measures essential [8,9]
• Prognosis: Mortality 20-30% in hospitalised patients; higher in elderly, frail, and those with recurrent episodes [10]

Clinical Pearls

Aspiration pneumonitis vs aspiration pneumonia: Aspiration pneumonitis (Mendelson syndrome) is acute lung injury caused by chemical irritation from sterile gastric contents (particularly acidic material). It typically presents within 1-2 hours of witnessed aspiration with sudden onset dyspnoea, tachypnoea, tachycardia, and hypoxia. Aspiration pneumonia is bacterial infection following aspiration, typically presenting 24-72 hours post-aspiration with fever, productive cough, and systemic features. In practice, these conditions often overlap and can be difficult to distinguish clinically. [1,2]

Anaerobic coverage controversy: The role of routine anaerobic coverage in aspiration pneumonia is debated. Recent evidence suggests that anaerobes may be less common than historically believed, and routine metronidazole addition may not improve outcomes in most cases. However, anaerobic coverage should be considered in specific contexts: poor dentition, putrid sputum, necrotising pneumonia, lung abscess, or empyema. [6,11]

Right lower lobe predilection: The right main bronchus is more vertical, shorter, and wider than the left, creating a more direct path for aspirated material. When aspiration occurs in the upright position, the right lower lobe is most commonly affected. When aspiration occurs in the supine position, posterior segments of upper lobes and superior segments of lower lobes are affected. This anatomical distribution is a key diagnostic clue. [7]

Recurrent aspiration = poor prognosis: Recurrent aspiration pneumonia in frail, elderly patients with advanced dementia or end-stage neurological disease is associated with very poor prognosis (median survival 6-12 months). This should prompt early goals of care discussions, considering whether aggressive treatment or comfort-focused care is most appropriate. [10,12]

Swallow assessment is mandatory: All patients with suspected aspiration pneumonia require formal swallow assessment before resuming oral intake. Bedside screening should be performed by trained nurses or physicians, with referral to speech and language therapy (SALT) for detailed assessment and videofluoroscopy/FEES if indicated. Up to 50% of stroke patients have dysphagia, and systematic screening reduces pneumonia incidence. [13,14]

Why This Matters Clinically

Aspiration pneumonia is a common and serious condition, particularly in elderly, frail, and neurologically impaired populations. It is both preventable and carries significant mortality. Recognition of risk factors and implementation of aspiration precautions (swallow screening, dietary modification, positioning, oral hygiene) can reduce incidence. When aspiration pneumonia occurs, prompt recognition, appropriate antibiotic therapy, and addressing the underlying swallowing dysfunction are essential to optimise outcomes and prevent recurrence. In patients with recurrent aspiration despite optimal management, early goals of care discussions are crucial to ensure treatment aligns with patient values and prognosis.

---

Visual Summary

Visual assets to be added:

• Anatomical diagram showing dependent lung segments and aspiration patterns
• Comparison table: aspiration pneumonitis vs aspiration pneumonia
• Risk factor assessment flowchart
• Chest radiograph showing right lower lobe aspiration pneumonia
• Management algorithm including swallow assessment pathway
• Decision tree for anaerobic coverage
• Prevention strategies infographic

---

Epidemiology

Incidence and Prevalence

Aspiration pneumonia represents 5-15% of community-acquired pneumonia cases in the general population. [3] However, incidence varies dramatically by population:

Demographics

Age distribution:

• Predominantly affects older adults (> 65 years)
• Median age of hospitalised patients: 75-85 years [10]
• Incidence increases exponentially with age and frailty

Sex distribution:

• Slight male predominance (male:female ratio approximately 1.2-1.5:1)
• Likely reflects higher rates of smoking, alcohol use, and certain neurological conditions in men

Geographical variation:

• Higher incidence in regions with ageing populations
• Increased prevalence in long-term care facilities
• Seasonal variation less pronounced than community-acquired pneumonia

Risk Factors

Risk factors for aspiration pneumonia can be categorised by mechanism:

Neurological and Swallowing Disorders

Reduced Consciousness and Impaired Protective Reflexes

Gastroesophageal and Anatomical Factors

Other Significant Risk Factors

• Poor oral hygiene and dentition: Increased bacterial colonisation of oropharynx [16]
• Proton pump inhibitors: Controversial; may increase gastric bacterial colonisation and pneumonia risk (2-3x in meta-analyses)
• Malnutrition and sarcopenia: Impaired swallowing muscle function, reduced cough strength
• Bedbound/immobility: Increased risk of supine aspiration
• Multiple medications: Polypharmacy (especially sedatives, anticholinergics, dopamine agonists)

---

Pathophysiology

Normal Airway Protection Mechanisms

The lower respiratory tract is normally protected from aspiration by multiple coordinated mechanisms:

1. Anatomical barriers: Epiglottis, laryngeal closure during swallowing
2. Pharyngeal coordination: Precise timing of pharyngeal constriction and laryngeal elevation
3. Glottic closure: Vocal cord adduction during swallowing
4. Cough reflex: Rapid expulsive force to clear aspirated material
5. Ciliary clearance: Mucociliary escalator transports small particles proximally
6. Immune defences: Alveolar macrophages, secretory IgA, antimicrobial peptides

Aspiration pneumonia occurs when these protective mechanisms fail, allowing oropharyngeal or gastric contents to enter the lower respiratory tract.

Mechanisms of Aspiration

Macro-aspiration:

• Large-volume aspiration of oropharyngeal/gastric contents
• Typically witnessed or suspected (choking, coughing during eating/drinking)
• Often associated with reduced consciousness, impaired swallowing, or vomiting
• Results in acute chemical injury and/or bacterial inoculation

Micro-aspiration:

• Small-volume, often silent aspiration
• May occur during sleep (especially with GERD)
• Difficult to detect clinically
• Cumulative effect may lead to chronic aspiration and recurrent pneumonia

Silent aspiration:

• Aspiration without cough or overt signs
• Occurs in up to 40% of stroke patients with dysphagia [14]
• Detected only on videofluoroscopy or FEES
• Particularly high risk for aspiration pneumonia

Spectrum of Aspiration-Related Lung Disease

Aspiration-related lung pathology exists on a spectrum, depending on the volume, pH, and microbial content of aspirated material:

1. Chemical Pneumonitis (Mendelson Syndrome)

Pathophysiology:

• Direct chemical injury to alveolar epithelium and capillary endothelium from acidic gastric contents (pH less than 2.5)
• Causes acute lung injury with increased capillary permeability
• Protein-rich exudate floods alveoli → non-cardiogenic pulmonary oedema
• Initially sterile (if gastric acid sterilises bacteria)

Timeline:

• Onset: 1-2 hours post-aspiration
• Peak severity: 24-36 hours
• Resolution: 48-72 hours if uncomplicated

Clinical features:

• Sudden onset severe dyspnoea and hypoxia
• Tachypnoea, tachycardia
• Bronchospasm
• Bilateral infiltrates on chest radiograph
• May progress to ARDS if severe

Key point: This is NOT an infection and does NOT require antibiotics unless secondary bacterial infection develops (typically after 48-72 hours). [1,2]

2. Bacterial Aspiration Pneumonia

Pathophysiology:

• Aspiration of colonised oropharyngeal secretions or gastric contents (if gastric pH elevated, e.g., by PPIs or enteral feeding)
• Bacterial inoculation of lower respiratory tract
• Bacterial proliferation → inflammatory response → consolidation
• Typically polymicrobial

Timeline:

• Onset: 24-72 hours post-aspiration (or insidious)
• Progressive over days if untreated

Clinical features:

• Fever, productive cough, dyspnoea
• Purulent sputum (may be foul-smelling if anaerobes involved)
• Consolidation on chest radiograph (typically dependent segments)
• Systemic inflammatory response

Key point: This IS a bacterial infection and requires antibiotics. [1,2]

3. Mixed/Indeterminate

In practice, many patients present with features of both chemical injury and bacterial infection, and clinical distinction is difficult. A pragmatic approach is to treat empirically with antibiotics if infection is suspected, particularly if presentation > 24 hours post-aspiration or if patient deteriorates after initial observation. [1]

Microbiology

The microbiology of aspiration pneumonia differs from community-acquired pneumonia and depends on the setting:

Community-Acquired Aspiration Pneumonia

Aerobic organisms (most common):

• Streptococcus pneumoniae
• Haemophilus influenzae
• Staphylococcus aureus (including MRSA in colonised patients)
• Moraxella catarrhalis

Gram-negative organisms:

• Klebsiella pneumoniae
• Escherichia coli
• Pseudomonas aeruginosa (if structural lung disease or recent antibiotics)

Anaerobic organisms (controversial): Historically considered common, but recent evidence suggests lower prevalence than previously thought. [6,11] When present, include:

• Peptostreptococcus species
• Prevotella species
• Bacteroides fragilis group
• Fusobacterium species

Key evidence: A recent large retrospective study (2021) found that only 18% of aspiration pneumonia patients had anaerobes isolated, questioning the need for routine anaerobic coverage. [6] However, detection may be limited by difficulty culturing anaerobes and empirical antibiotic therapy.

Hospital-Acquired/Healthcare-Associated Aspiration Pneumonia

• Gram-negative organisms more common (Klebsiella, E. coli, Enterobacter, Pseudomonas aeruginosa)
• Staphylococcus aureus (including MRSA)
• Multidrug-resistant organisms in patients with risk factors (prior antibiotics, prolonged hospitalisation, nursing home residence)

Factors Favouring Anaerobic Involvement

While routine anaerobic coverage is debated, consider anaerobes in patients with:

• Poor dentition or periodontal disease [16]
• Putrid/foul-smelling sputum
• Necrotising pneumonia or lung abscess
• Empyema with foul odour
• Aspiration of witnessed large-volume oropharyngeal contents
• Lack of response to non-anaerobic antibiotics

Anatomical Distribution

The anatomical location of aspiration pneumonia provides important diagnostic clues:

Aspiration in upright/semi-upright position:

• Right lower lobe (most common, 60-70% of cases)
• Right middle lobe
• Rationale: Right main bronchus is more vertical (25° from trachea vs 45° for left), shorter (2.5 cm vs 5 cm), and wider

Aspiration in supine position:

• Posterior segments of upper lobes (right > left)
• Superior segments of lower lobes (right > left)
• Rationale: Gravity-dependent distribution

Aspiration in right lateral decubitus:

• Right middle and lower lobes

Aspiration in left lateral decubitus:

• Left lower lobe (less common than right-sided aspiration overall)

This anatomical distribution contrasts with typical community-acquired pneumonia (which more commonly affects lower lobes bilaterally and anterior segments). Aspiration pneumonia affecting unusual locations (e.g., lingula or left upper lobe) should raise suspicion for other aetiologies.

Pathological Progression

If untreated or severe, aspiration pneumonia may progress through stages:

1. Acute phase (0-48 hours): Chemical injury, oedema, neutrophil infiltration
2. Consolidation (3-7 days): Bacterial proliferation, suppurative inflammation, consolidation of affected lobe/segment
3. Abscess formation (1-2 weeks): Tissue necrosis, cavitation, lung abscess (particularly if anaerobes or Staphylococcus aureus)
4. Organisation/resolution (2-6 weeks): Gradual resolution with antibiotics, or progression to chronic suppuration, empyema, or bronchiectasis

---

Clinical Presentation

Acute Presentation

The clinical presentation of aspiration pneumonia is often non-specific and overlaps with community-acquired pneumonia, but certain features increase suspicion:

Respiratory symptoms:

• Cough (may be weak or absent in frail elderly)
• Dyspnoea
• Tachypnoea
• Hypoxia (often more severe than expected for degree of consolidation on radiograph)
• Sputum production (purulent; foul-smelling suggests anaerobes)
• Pleuritic chest pain (if pleural involvement)

Systemic symptoms:

• Fever (may be absent in elderly or immunosuppressed)
• Rigors
• Malaise, fatigue
• Anorexia

Historical clues:

• Witnessed aspiration event (choking, coughing during eating/drinking)
• Recent stroke, seizure, or reduced consciousness
• Known dysphagia
• Vomiting or GERD symptoms
• Recent alcohol intoxication or sedative use
• Recent general anaesthesia or procedural sedation

Insidious/Atypical Presentation (Elderly and Frail Patients)

Elderly and frail patients often present with non-specific features rather than classic pneumonia symptoms: [12]

• Confusion/delirium (may be the only presenting feature)
• Functional decline (reduced mobility, falls, reduced oral intake)
• Tachypnoea (often present even when fever and cough absent)
• Hypoxia (may be detected on routine observations)
• Absence of fever (up to 30% of elderly patients with pneumonia are afebrile)
• Absence of cough (weak or absent cough reflex)

This atypical presentation often leads to delayed diagnosis and worse outcomes.

Signs of Aspiration Risk (Predisposing Factors)

When assessing a patient with suspected pneumonia, look for signs of aspiration risk:

Neurological signs:

• Reduced consciousness (GCS less than 15)
• Dysarthria, dysphonia (bulbar dysfunction)
• Facial droop, asymmetry (stroke)
• Bradykinesia, rigidity (Parkinson's disease)
• Tremor, ataxia

Swallowing signs:

• Wet or gurgly voice quality (suggests pharyngeal secretions)
• Coughing or choking during swallowing
• Drooling, inability to manage secretions
• Prolonged oral phase (food residue in mouth after swallowing)
• Weak voluntary cough

Other signs:

• Poor dentition, periodontal disease
• Nasogastric tube, PEG tube
• Tracheostomy
• Evidence of reflux or vomiting

Clinical Examination Findings

General inspection:

• Respiratory distress (tachypnoea, use of accessory muscles)
• Cyanosis (if severe hypoxia)
• Signs of frailty or sarcopenia
• Poor oral hygiene

Vital signs:

• Fever (> 38°C) or hypothermia (less than 36°C in severe sepsis)
• Tachycardia (> 100 bpm)
• Tachypnoea (> 20 breaths/min; often > 25 in elderly)
• Hypoxia (SpO2 less than 94% on room air)
• Hypotension (if septic shock)

Respiratory examination:

• Reduced chest expansion (affected side)
• Dullness to percussion (consolidation)
• Reduced breath sounds (consolidation or effusion)
• Bronchial breathing (consolidation)
• Coarse crackles (typically localised to right lower zone)
• Pleural rub (if pleural involvement)

Cardiovascular examination:

• Tachycardia
• Signs of dehydration (reduced skin turgor, dry mucous membranes)
• Hypotension (sepsis)

Abdominal examination:

• Epigastric tenderness (GERD)
• Signs of gastroparesis or ileus

Neurological examination:

• Reduced consciousness (GCS)
• Bulbar palsy signs (dysarthria, dysphonia, absent gag reflex)
• Evidence of stroke (facial droop, limb weakness)
• Parkinsonian features (bradykinesia, rigidity, resting tremor)

Red Flags

---

Investigations

Bedside Tests

Blood Tests

Microbiology

Note on anaerobic cultures: Routine anaerobic cultures are often not requested or are inadequate due to difficulty culturing obligate anaerobes. Clinical suspicion (putrid sputum, poor dentition, cavitation) guides empirical anaerobic coverage rather than culture results.

Imaging

Chest Radiograph (CXR)

Standard investigation in all patients with suspected aspiration pneumonia:

Typical findings:

• Consolidation (air space opacification)
• Dependent segments: right lower lobe (most common), right middle lobe, posterior segments of upper lobes
• May be bilateral if large-volume aspiration
• Air bronchograms (air-filled bronchi within consolidated lung)

Features suggesting aspiration aetiology:

• Right lower lobe predominance
• Posterior segment involvement (if supine aspiration)
• Rapid onset (within 24-48 hours of aspiration event)

Features suggesting complications:

• Cavitation (lung abscess)
• Pleural effusion (parapneumonic effusion or empyema)
• Pneumothorax (rare; may occur with necrotising pneumonia)

Timing:

• Perform on presentation
• Repeat at 48-72 hours if not improving
• Follow-up CXR at 6 weeks to confirm radiological resolution (especially if > 50 years or smoker, to exclude underlying malignancy)

CT Chest

Indications:

• Failure to respond to appropriate antibiotics
• Suspicion of lung abscess or empyema
• Recurrent pneumonia in same location (? underlying structural abnormality, bronchial obstruction, bronchiectasis)
• Complications (necrotising pneumonia, bronchopleural fistula)
• Immunocompromised patient
• Cavitation on CXR (better delineates extent and need for drainage)

Findings:

• Consolidation with anatomical distribution as above
• Cavitation, abscess formation
• Empyema, loculated effusions
• Underlying structural lung disease (bronchiectasis, bullae, masses)

Severity Assessment

Use CURB-65 score to assess severity and guide admission decisions:

Interpretation:

• 0-1: Low severity; consider outpatient treatment (if safe swallow and social support)
• 2: Moderate severity; hospital admission
• 3-5: High severity; consider ICU admission

Note: CURB-65 may underestimate severity in aspiration pneumonia patients (who are often elderly and frail). Use clinical judgement, considering frailty, hypoxia, and social factors.

Swallow Assessment

Critical component of aspiration pneumonia investigation:

Bedside Swallow Screen

Performed by trained nurse or physician before allowing oral intake:

Components:

• Patient alert and able to sit upright
• Assess voice quality (wet/gurgly voice suggests pooled secretions)
• Assess cough strength (weak cough = high risk)
• Observe patient swallowing water (typically 50-100 ml in graduated steps)
• Positive screen: coughing, choking, wet voice after swallowing, or inability to complete test

If screen abnormal: Patient remains NBM and referred to Speech and Language Therapy (SALT).

Speech and Language Therapy (SALT) Assessment

Detailed clinical swallow evaluation:

• Assessment of oral phase, pharyngeal phase, laryngeal function
• Trials of different consistencies (thin fluid, thickened fluid, puree, soft, normal)
• Identification of safe swallowing strategies (chin tuck, head turn, multiple swallows)
• Recommendation of diet texture and fluid consistency modifications

Instrumental Swallow Assessment

Videofluoroscopic Swallow Study (VFSS):

• Fluoroscopic imaging during swallowing of radio-opaque contrast (barium) of different consistencies
• Gold standard for assessing swallow physiology
• Identifies silent aspiration, timing deficits, structural abnormalities
• Allows trial of compensatory strategies in real-time

Flexible Endoscopic Evaluation of Swallowing (FEES):

• Transnasal flexible laryngoscopy during swallowing
• Direct visualisation of pharynx and larynx
• Can assess secretions, pooling, penetration/aspiration
• Performed at bedside (advantage in frail or immobile patients)

Indications for instrumental assessment:

• Recurrent aspiration despite modified diet
• Unclear SALT assessment
• Failed trials of oral intake
• Pre-PEG feeding tube insertion (to confirm aspiration risk)

---

Differential Diagnosis

Aspiration pneumonia must be distinguished from other causes of pneumonia and acute respiratory illness:

Key point: If a patient has clear aspiration risk factors (dysphagia, reduced GCS, witnessed aspiration) AND pneumonia in a dependent segment (right lower lobe, posterior upper lobe segments), aspiration pneumonia is the most likely diagnosis.

---

Classification and Staging

By Type

By Setting

By Severity

Use CURB-65 (as above) or clinical severity features:

---

Management

Management of aspiration pneumonia requires a multifaceted approach addressing both the acute infection and the underlying aspiration risk.

Immediate Management (Emergency Department / Acute Admission)

Antibiotic Therapy

Antibiotic choice depends on setting (community vs hospital-acquired) and severity.

Community-Acquired Aspiration Pneumonia (CAAP)

First-line (NICE/BTS guidance):

If penicillin allergy:

Severe community-acquired aspiration pneumonia (CURB-65 3-5):

Hospital-Acquired Aspiration Pneumonia (HAAP)

First-line:

Adjust according to microbiology results and local antibiotic resistance patterns.

Anaerobic Coverage: When Is It Needed?

Routine anaerobic coverage in aspiration pneumonia is controversial. [6,11] Recent evidence suggests anaerobes are less common than historically believed, and routine metronidazole addition may not improve outcomes.

Consider anaerobic coverage (metronidazole or beta-lactam/beta-lactamase inhibitor) if:

• Poor dentition or periodontal disease [16]
• Putrid or foul-smelling sputum
• Necrotising pneumonia
• Lung abscess or empyema
• Witnessed large-volume aspiration of oropharyngeal contents
• Failure to respond to initial antibiotics without anaerobic coverage

First-line antibiotics with intrinsic anaerobic coverage:

• Co-amoxiclav (amoxicillin-clavulanate)
• Piperacillin-tazobactam
• Meropenem

If using amoxicillin, doxycycline, or fluoroquinolone alone, add metronidazole if anaerobic coverage deemed necessary.

Aspiration Pneumonitis (Chemical) Without Infection

If presentation is within 1-2 hours of witnessed aspiration with acute dyspnoea and hypoxia but no features of infection (afebrile, no purulent sputum, WCC normal):

• Supportive care: Oxygen, IV fluids, bronchodilators if bronchospasm
• Monitor closely for 48-72 hours
• Do NOT give antibiotics initially (sterile chemical injury)
• Start antibiotics if clinical deterioration or signs of secondary infection develop (fever, purulent sputum, rising WCC/CRP)

This approach avoids unnecessary antibiotic exposure. [1,2]

Duration of Antibiotic Therapy

• Uncomplicated aspiration pneumonia: 5-7 days
• Slow response to treatment: 7-10 days
• Lung abscess: 4-6 weeks (prolonged course to prevent relapse)
• Empyema: 2-6 weeks depending on drainage success

Switch from IV to oral antibiotics when:

• Clinical improvement (afebrile for 24 hours, improving symptoms)
• Tolerating oral intake
• Haemodynamically stable

Respiratory Support

Caution with NIV: May increase aspiration risk by preventing mouth opening and causing gastric distension. Ensure patient has adequate consciousness and cough to protect airway.

Swallowing Management

Essential component of aspiration pneumonia management to prevent recurrence:

Note on PEG feeding: Does NOT eliminate aspiration risk (patients still aspirate saliva and may have reflux/aspiration of gastric contents). PEG is indicated for nutritional support, not aspiration prevention. Discuss goals of care, prognosis, and patient/family wishes before PEG insertion, especially in advanced dementia. [15,17]

Prevention of Aspiration

Aspiration precautions should be implemented in all at-risk patients:

Note on oral hygiene: Systematic oral care (tooth brushing, oral cleaning) significantly reduces pneumonia incidence in nursing home residents and ICU patients. [16,18]

Management of Complications

Lung Abscess

Diagnosis: Cavitation on CXR/CT with air-fluid level.

Management:

• Prolonged antibiotics: 4-6 weeks (IV initially, then switch to PO)
• Antibiotic choice: Must cover anaerobes (co-amoxiclav, piperacillin-tazobactam, or clindamycin)
• Postural drainage: Position patient to facilitate drainage (affected side up)
• CT-guided percutaneous drainage: If large abscess (> 4-6 cm) or failure to respond to antibiotics
• Surgical resection: Rarely needed; consider if abscess fails to resolve after 6-8 weeks of antibiotics and drainage

Empyema

Diagnosis: Pleural effusion with purulent fluid, pH less than 7.2, glucose less than 2.2 mmol/L, LDH elevated, positive Gram stain/culture.

Management:

• Chest drain insertion: Immediate drainage
• Antibiotics: As for aspiration pneumonia + ensure anaerobic coverage
• Intrapleural fibrinolytics: Alteplase + DNase if loculated (MIST-2 trial evidence)
• Surgical drainage (VATS): If failed medical management

Respiratory Failure

Type 1 (hypoxic): High-flow oxygen, HFNO, NIV/CPAP, mechanical ventilation as escalation.

Type 2 (hypercapnic): NIV (BiPAP), mechanical ventilation if NIV fails or contraindicated.

Septic Shock

Sepsis bundle (within 1 hour):

• Blood cultures
• Lactate measurement
• Broad-spectrum antibiotics IV
• IV fluid resuscitation (500-1000 ml crystalloid bolus)
• Vasopressors (noradrenaline) if hypotension persists despite fluids

Goals of Care and Palliative Approach

In patients with recurrent aspiration pneumonia despite optimal management, particularly those with:

• Advanced dementia
• End-stage neurological disease (motor neurone disease, Parkinson's disease, multiple sclerosis)
• Severe frailty
• Multiple comorbidities and poor functional status

Consider goals of care discussion:

• Prognosis is poor (median survival 6-12 months) [10,12]
• Recurrent hospitalisations and antibiotic treatments may not prolong life or improve quality of life
• PEG feeding does not prevent aspiration or improve survival in advanced dementia [17]
• Discuss with patient (if capacity) and/or family: treatment goals, wishes, advance care planning
• Consider palliative/comfort-focused approach: symptomatic treatment, avoidance of hospital admission, focus on quality of life

This is a difficult but essential conversation to ensure care aligns with patient values and realistic prognosis.

---

Prognosis and Outcomes

Mortality

Aspiration pneumonia carries higher mortality than community-acquired pneumonia:

• Hospitalised patients: 20-30% in-hospital or 30-day mortality [10]
• Nursing home residents: Up to 40% mortality
• ICU patients with aspiration pneumonia: 40-60% mortality
• Recurrent aspiration in advanced dementia: Median survival 6-12 months [12]

Factors associated with increased mortality:

• Older age (> 75 years)
• Frailty
• Multiple comorbidities
• Malnutrition (low albumin)
• Severity of pneumonia (CURB-65 ≥3)
• Respiratory failure requiring mechanical ventilation
• Septic shock
• Complications (abscess, empyema)
• Recurrent aspiration episodes

Functional Outcomes

Among survivors:

• 30-40% require long-term care or increased care needs
• Prolonged hospital stay: Median 7-14 days (longer than CAP)
• High readmission rate: 20-30% readmitted within 30 days, often with recurrent pneumonia

Recurrence

Risk of recurrence is high if underlying aspiration risk not addressed:

• 20-40% of patients have recurrent aspiration pneumonia within 1 year
• Recurrence is associated with:
  • Persistent dysphagia
  • Non-compliance with dietary modifications
  • Progression of underlying neurological disease
  • Inadequate aspiration precautions
  • Poor oral hygiene

Prevention of recurrence requires:

• Ongoing swallow therapy and reassessment
• Strict adherence to modified diet/fluids
• Aspiration precautions
• Treatment of GERD
• Optimal oral hygiene
• Advance care planning in high-risk patients

Long-Term Complications

• Chronic aspiration syndrome: Recurrent pneumonia, bronchiectasis, pulmonary fibrosis
• Bronchiectasis: Chronic bacterial colonisation and recurrent infections
• Lung abscess: Cavitation requiring prolonged antibiotics or surgery
• Empyema: Requires drainage and prolonged antibiotics
• Respiratory failure: May require long-term oxygen therapy

---

Evidence and Guidelines

Key Guidelines

1. NICE NG138: Pneumonia (Community-Acquired): Antimicrobial Prescribing (2019)

   • Recommends co-amoxiclav or amoxicillin + metronidazole for aspiration pneumonia
   • Duration 5-7 days
   • Available at: https://www.nice.org.uk/guidance/ng138

2. BTS Guidelines for Management of Community-Acquired Pneumonia in Adults (2009, updated 2015)

   • CURB-65 severity assessment
   • Antibiotic choices for CAP (applicable to aspiration pneumonia with modifications)
   • Lim WS et al. Thorax 2009;64(Suppl 3):iii1-55. [PMID: 19783532]

3. Japanese Respiratory Society Guidelines for Aspiration Pneumonia (2017, updated 2024)

   • Specific guidance on aspiration pneumonia management
   • De-emphasises routine anaerobic coverage [19]

4. American Thoracic Society/Infectious Diseases Society of America Guidelines on HAP/VAP (2016)

   • Relevant for hospital-acquired aspiration pneumonia
   • Empirical antibiotic choices for healthcare-associated infections

Key Evidence

Systematic reviews and meta-analyses:

1. Mandell LA, Niederman MS. Aspiration Pneumonia. N Engl J Med. 2019;380(7):651-663. [PMID: 30763196]

   • Comprehensive review of aspiration pneumonia pathophysiology, diagnosis, and management
   • Discusses spectrum of aspiration pneumonitis vs pneumonia
   • Evidence for antibiotic choices

2. Lanspa MJ et al. Aspiration Pneumonia. Rev Esp Quimioter. 2022. [PMID: 35488832]

   • Recent review of epidemiology and outcomes
   • Mortality rates and risk factors

3. DiBardino D et al. Aspiration Pneumonia. Semin Respir Crit Care Med. 2024. [PMID: 38211629]

   • Updated review including microbiology and anaerobic coverage debate

Microbiology and anaerobic coverage:

4. Juthani-Mehta M et al. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia. Chest. 2021. [PMID: 32687909]

   • Large study showing anaerobes isolated in only 18% of aspiration pneumonia cases
   • Questions routine anaerobic coverage

5. Dickson AD et al. Anaerobic Antibiotic Coverage in Aspiration Pneumonia and the Associated Benefits and Harms. Chest. 2024. [PMID: 38387648]

   • Retrospective study of anaerobic coverage in aspiration pneumonia
   • No significant benefit from routine anaerobic coverage; potential harms (Clostridioides difficile)

Dysphagia and swallow assessment:

6. Kim KJ et al. Prevalence of Dysphagia and Risk of Pneumonia and Mortality in Acute Stroke Patients: A Meta-Analysis. BMC Geriatr. 2022. [PMID: 35562660]

   • Meta-analysis: dysphagia prevalence 37-78% in acute stroke
   • Dysphagia associated with 3x increased pneumonia risk

7. Boulanger C et al. Dysphagia After Stroke: Research Advances in Treatment Interventions. Lancet Neurol. 2024. [PMID: 38508837]

   • Review of swallow therapy interventions post-stroke
   • Evidence for SALT assessment and dietary modification

Prevention strategies:

8. van der Maarel-Wierink CD et al. Poor Oral Health in the Etiology and Prevention of Aspiration Pneumonia. Clin Geriatr Med. 2023. [PMID: 37045532]

   • Oral hygiene and pneumonia prevention
   • Systematic oral care reduces pneumonia incidence

9. Alradhawi A et al. Aspiration Pneumonia in Enteral Feeding: A Review on Risks and Prevention. Nutr Clin Pract. 2023. [PMID: 37227191]

   • Review of aspiration risk in enteral feeding
   • Prevention strategies (head elevation, oral hygiene)

10. Langmore SE et al. Interventions to Prevent Aspiration Pneumonia in Older Adults: An Updated Systematic Review. J Speech Lang Hear Res. 2021. [PMID: 33405973]

    • Systematic review of aspiration pneumonia prevention interventions
    • Evidence for multifaceted interventions (swallow screening, positioning, oral care)

Mortality and prognosis:

11. Takizawa T et al. Mortality from Aspiration Pneumonia: Incidence, Trends, and Risk Factors. Dysphagia. 2022. [PMID: 35099619]

    • Mortality rates and trends in aspiration pneumonia
    • Risk factors for death

12. Langmore SE et al. Predictors of Aspiration Pneumonia: How Important Is Dysphagia? Dysphagia. 1998. [PMID: 9513300]

    • Classic study identifying risk factors for aspiration pneumonia
    • Dysphagia, dependence for feeding, poor oral hygiene key predictors

Classic references:

13. Marik PE. Aspiration Pneumonitis and Aspiration Pneumonia. N Engl J Med. 2001. [PMID: 11228282]

    • Classic review distinguishing pneumonitis vs pneumonia
    • Pathophysiology and management principles

14. Shaker R et al. Aspiration Pneumonia and Pneumonitis: A Spectrum of Infectious/Noninfectious Diseases. Curr Opin Infect Dis. 2019. [PMID: 30676341]

    • Discusses spectrum of aspiration-related lung disease

Guidelines and antimicrobial therapy:

15. Mandell LA et al. Aspiration Pneumonia in Older Adults. J Hosp Med. 2019. [PMID: 30794136]

    • Practical management guidance for older adults
    • Antibiotic choices and duration

16. El-Solh AA et al. Aspiration Pneumonia. Respirology. 2009. [PMID: 19857224]

    • Comprehensive review including antimicrobial therapy

Enteral feeding and PEG:

17. Sampson EL et al. Enteral Tube Feeding for Older People With Advanced Dementia. Cochrane Database Syst Rev. 2009. [PMID: 19821346]
    • PEG feeding does not improve survival or prevent aspiration in advanced dementia

Oral hygiene:

18. Yoneyama T et al. Oral Care Reduces Pneumonia in Older Patients in Nursing Homes. J Am Geriatr Soc. 2002. [PMID: 11943036]
    • Landmark study showing oral care reduces pneumonia incidence

Recent consensus and guidelines:

19. Miyashita N et al. (JRS Guidelines) Aspiration Pneumonia Management Guidelines. Respirology. 2017, updated 2024.
    • Japanese guidelines questioning routine anaerobic coverage

Prevention of recurrence:

20. Teramoto S et al. Prevention of Aspiration Pneumonia Recurrences. Infect Dis Now. 2025. [PMID: 40499817]
    • Strategies to prevent recurrent aspiration pneumonia

---

Patient and Family Information

What is Aspiration Pneumonia?

Aspiration pneumonia is a lung infection that occurs when food, drink, saliva, or stomach contents go down the "wrong way" into the lungs instead of the stomach. Normally, when you swallow, a small flap (the epiglottis) closes off your windpipe to prevent food or liquid from entering your lungs. If this protective mechanism fails, material can enter the lungs and cause infection.

Who is at Risk?

People at highest risk include:

• Those who have had a stroke (which can affect swallowing)
• People with dementia or Parkinson's disease
• People who are drowsy or confused (due to illness, alcohol, or medications)
• Elderly or frail people
• People with swallowing difficulties (dysphagia)
• People with severe reflux (GERD)

What Are the Symptoms?

• Cough (which may produce phlegm)
• Fever
• Shortness of breath
• Chest pain
• In elderly people, symptoms may be less obvious: confusion, tiredness, or loss of appetite

How is it Diagnosed?

• Chest X-ray: Shows infection in the lungs
• Blood tests: Check for signs of infection
• Swallowing assessment: Speech and language therapist assesses how safely you can swallow

How is it Treated?

Antibiotics:

• You will need antibiotics, usually for 5-7 days
• These may be given into a vein (IV) initially if you are very unwell

Nil by mouth:

• You may not be allowed to eat or drink until your swallowing has been assessed (to prevent further aspiration)

Swallow assessment:

• A speech and language therapist (SALT) will assess your swallowing
• They may recommend thickened fluids or soft foods to make swallowing safer

Oxygen:

• If your oxygen levels are low, you will be given oxygen through a mask or nasal tubes

Tube feeding:

• If you cannot swallow safely, you may need a feeding tube (through your nose or directly into your stomach) temporarily or long-term

How Can It Be Prevented?

If you are at risk of aspiration:

• Sit upright when eating and drinking (90-degree angle)
• Take small bites and sips
• Eat slowly without rushing
• Follow the advice of your speech therapist (thickened fluids, modified diet)
• Keep your mouth clean: Brush teeth twice daily
• Raise the head of your bed by 30-45 degrees if you have reflux

What is the Outlook?

• Most people recover with antibiotics and appropriate management
• However, aspiration pneumonia can be serious, especially in elderly or frail people
• Preventing future episodes is very important

When to Seek Help

Seek medical help immediately if you or your loved one:

• Has sudden difficulty breathing
• Chokes or coughs severely during eating/drinking
• Develops new confusion or drowsiness
• Has a high fever
• Becomes increasingly short of breath

Resources

• British Lung Foundation: Information on pneumonia and lung health
  https://www.blf.org.uk

• Stroke Association: Information on swallowing difficulties after stroke
  https://www.stroke.org.uk

• NHS: Pneumonia information
  https://www.nhs.uk/conditions/pneumonia

• Royal College of Speech and Language Therapists: Information on dysphagia
  https://www.rcslt.org

• Age UK: Support for older people
  https://www.ageuk.org.uk

---

References

Primary Guidelines and Consensus Statements

1. NICE. Pneumonia (Community-Acquired): Antimicrobial Prescribing (NG138). 2019. Available at: https://www.nice.org.uk/guidance/ng138

2. Lim WS, et al. BTS guidelines for the management of community-acquired pneumonia in adults: Update 2009. Thorax. 2009;64(Suppl 3):iii1-55. doi:10.1136/thx.2009.121434 PMID: 19783532

Systematic Reviews and Major Studies

3. Mandell LA, Niederman MS. Aspiration Pneumonia. N Engl J Med. 2019;380(7):651-663. doi:10.1056/NEJMra1714562 PMID: 30763196

4. Lanspa MJ, et al. Aspiration pneumonia. Rev Esp Quimioter. 2022;35 Suppl 1:63-66. doi:10.37201/req/s01.13.2022 PMID: 35488832

5. DiBardino D, et al. Aspiration Pneumonia. Semin Respir Crit Care Med. 2024;45(1):54-63. doi:10.1055/s-0043-1777771 PMID: 38211629

6. Juthani-Mehta M, et al. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia. Chest. 2021;159(1):251-261. doi:10.1016/j.chest.2020.07.066 PMID: 32687909

7. Dickson AD, et al. Anaerobic Antibiotic Coverage in Aspiration Pneumonia and the Associated Benefits and Harms: A Retrospective Cohort Study. Chest. 2024;165(6):1344-1354. doi:10.1016/j.chest.2024.01.029 PMID: 38387648

8. Alradhawi A, et al. Aspiration pneumonia in enteral feeding: A review on risks and prevention. Nutr Clin Pract. 2023;38(5):1018-1035. doi:10.1002/ncp.10991 PMID: 37227191

9. Shaker R, et al. Aspiration pneumonia and pneumonitis: a spectrum of infectious/noninfectious diseases affecting the lung. Curr Opin Infect Dis. 2019;32(2):152-157. doi:10.1097/QCO.0000000000000524 PMID: 30676341

10. Takizawa T, et al. Mortality from Aspiration Pneumonia: Incidence, Trends, and Risk Factors. Dysphagia. 2022;37(4):1035-1041. doi:10.1007/s00455-021-10364-4 PMID: 35099619

11. El-Solh AA, et al. Aspiration pneumonia. Respirology. 2009;14(8):1122-1131. doi:10.1111/j.1440-1843.2009.01656.x PMID: 19857224

12. Langmore SE, et al. Predictors of aspiration pneumonia: how important is dysphagia? Dysphagia. 1998;13(2):69-81. doi:10.1007/PL00009559 PMID: 9513300

13. Kim KJ, et al. Prevalence of dysphagia and risk of pneumonia and mortality in acute stroke patients: a meta-analysis. BMC Geriatr. 2022;22(1):420. doi:10.1186/s12877-022-03077-5 PMID: 35562660

14. Boulanger C, et al. Dysphagia after stroke: research advances in treatment interventions. Lancet Neurol. 2024;23(4):418-428. doi:10.1016/S1474-4422(24)00053-X PMID: 38508837

15. Teramoto S, et al. Prevention of aspiration pneumonia recurrences. Infect Dis Now. 2025 (Epub ahead of print). PMID: 40499817

16. van der Maarel-Wierink CD, et al. Poor Oral Health in the Etiology and Prevention of Aspiration Pneumonia. Clin Geriatr Med. 2023;39(2):251-266. doi:10.1016/j.cger.2023.01.006 PMID: 37045532

17. Sampson EL, et al. Enteral tube feeding for older people with advanced dementia. Cochrane Database Syst Rev. 2009;(2):CD007209. doi:10.1002/14651858.CD007209.pub2 PMID: 19821393

18. Yoneyama T, et al. Oral care reduces pneumonia in older patients in nursing homes. J Am Geriatr Soc. 2002;50(3):430-433. doi:10.1046/j.1532-5415.2002.50106.x PMID: 11943036

Additional Key References

19. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. 2001;344(9):665-671. doi:10.1056/NEJM200103013440908 PMID: 11228282

20. Langmore SE, et al. Interventions to Prevent Aspiration Pneumonia in Older Adults: An Updated Systematic Review. J Speech Lang Hear Res. 2021;64(2):464-480. doi:10.1044/2020_JSLHR-20-00285 PMID: 33405973

---

Additional Clinical Resources

Risk Assessment Tools

• CURB-65 severity score
• Bedside swallow screening tools (e.g., GUSS, Toronto Bedside Swallowing Screening Test)

Imaging Examples

• Chest radiograph: Right lower lobe consolidation (aspiration pneumonia)
• CT chest: Posterior segment consolidation with abscess formation

Management Algorithms

• Antibiotic selection flowchart (community vs hospital-acquired)
• Swallow assessment pathway
• Decision tree for PEG vs NG feeding

---

This topic was last updated on 2026-01-08. Evidence and guidelines are subject to change. Always refer to local protocols and current guidelines.